ID   MS-2 [Human mesothelioma]
AC   CVCL_E992
DR   Wikidata; Q54906762
RX   PubMed=2457437;
CC   Doubling time: ~72 hours (PubMed=2457437).
CC   Donor information: No history of asbestos exposure (PubMed=2457437).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=2457437;
RA   Hsu, Su-Ming
RA   Hsu, Pei-Ling
RA   Zhao, Xun
RA   Kao-Shan, Chien-Song
RA   Whang-Peng, Jacqueline
RT   "Establishment of human mesothelioma cell lines (MS-1, -2) and
RT   production of a monoclonal antibody (anti-MS) with diagnostic and
RT   therapeutic potential.";
RL   Cancer Res. 48:5228-5236(1988).
//